Furthermore, we pretreated PTC cells with the PARP-1 inhibitor 3-AB for 12h, 24h and 48h before 131I treatment, significantly protecting thyroid cancer cells from ATP exhaustion (Figure 6b)(Supplementary Figure S5b). The gene discussed is PARP1; the disease is thyroid gland carcinoma.